Swiss pharmaceutical giant Roche on Monday applied to market the firm’s first COVID-19 monoclonal antibody cocktail, Ronapreve (casirivimab/imdevimab), in the European Union. This is the final stage before Ronapreve, which
All posts in COVID-19
Researchers from the Complexity Science Hub in Vienna found out that, during the lockdown, women preferred to talk on the phone with a few select friends, while men were more
Children who develop COVID-19 rarely experience symptoms that last longer than 4 weeks, according to a large UK study published in The Lancet Child and Adolescent Health (1). In fact,
Machine-learning analysis identified high blood glucose levels as a risk factor for COVID-19 patients, according to a study published in Frontiers in Public Health (1). Researchers believe this explains why
Big data is not always enough to predict the course of a particular situation, according to a team from the Ludwig-Maximilians-University in Munich, Germany (1) When big data analysis reaches
A team of researchers from the Technical University of Munich, Germany, developed a faster and more reliable antibody test to determine the presence of antibodies for the new coronavirus, according
World awaits for temporary relaxation of intellectual property rights to vaccines against COVID-19
- Features -
Contrary to the position of the pharmaceutical industry, the procedures of forced transfer of licences should not be treated as a violation of patent rights, as they are, to a
Summary: Like after the Second World War, we face today once again a choice between freedom and totalitarianism, namely between an open society that recognizes every human being as a
Swiss company Helvetiq has launched Save Patient Zero, game’s project related to Covid 19, on Kickstarter. Hadi Barkat, CEO of the company, has answered our questions to explain this brand
“Europe must make progress on animal genomic editing.” Interview with J.P. Jégou, President of the French Veterinarian Academy”
- Research -
European Scientist was able to interview Jean-Pierre Jégou, President of the Académie Vétérinaire de France since the beginning of 2021, after five years as Secretary General, of this prestigious Academy